Molecular Structure (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01)
Tizanidine
Product Images NDC 53002-1437
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 53002-1437). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-1 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02)
Figure 3 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03)
Figure 4 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04)
This text describes a study with a mean dose of 26.8 mg and the improvement in Ashworth Score. The study was carried out in several weeks, with observations made at the end of each week, culminating in the Endpoint. The study observed the changes in the Ashworth Score over time and could therefore be used to evaluate the effectiveness of a treatment.*
Logo (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05)
Label Image (Lbl530021437)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
